Arnas Karužas is one of the few founders in the region who bridges the gap between clinical medicine and deep tech execution. As the CEO of Ligence, he leads a company that is transforming cardiac diagnostics by automating heart ultrasound (echocardiography) analysis using deep learning.

Under his leadership, Ligence has achieved what few European HealthTech startups manage: securing FDA clearance (and CE Class IIb certification, validating their AI as a medical device for the US and EU markets. Arnas also steered the company to raise over €3M in seed funding, attracting backing from Simpact Ventures and the European Innovation Council (EIC).

Beyond the boardroom, Arnas is a practicing cardiologist at the Lithuanian University of Health Sciences (LSMU) Kaunas Clinics and a researcher. This active clinical role ensures that Ligence's technology solves real-world workflow bottlenecks rather than theoretical problems. He is also a winner of the prestigious EIT Health InnoStars Awards.